Intratympanic steroids for inner ear disorders: A review

Audiology and Neurotology

Volumn 14, Issue 6, 2009, Pages 373-382

  Hu, Amanda ^a   Parnes, Lorne S ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Deafness; Inner ear therapy; Intratympanic steroids; M ni re's disease; Sudden sensorineural hearing loss

Indexed keywords

DRUG ADMINISTRATION ROUTES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; LABYRINTH DISEASES; TREATMENT OUTCOME; TYMPANIC MEMBRANE;

EID: 73349126109     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000241894     Document Type: Review

References (55)

1. Hamid M, Trune D: Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 434-440.
2. Kharodwala M, Makishima T: Sudden sensorineural hearing loss and intratympanic steroids (June 14, 2006). UTMB Grand Rounds Presentation. www.utmb.edu/otoref/ Grnds/SNHL-060614/SNHL-060614.doc (accessed July 1, 2009).
3. Parnes LS, Sun A, Freeman DJ: Corticosteroid pharmacokinetics in the inner ear fluids: An animal study followed by clinical application. Laryngoscope 1999; 109: 1-17.
4. Chandrasekhar S, Rubinstein R, Kwartler J, et al: Dexamethasone pharmacokinetics in the inner ear: Comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000; 122: 521-528.
5. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF: Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007; 117: 3-15.
6. Stroup DF, Berlin JA, Morton SC, et al: Metaanalysis of observational studies in epidemiology: A proposal for reporting. JAMA 2000; 283: 2008-2012.
7. Berlin JA: Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group. Lancet 1997; 350: 185-186.
8. Alles MJRC, der Gaag MA, Stokroos RJ: Intratympanic steroid therapy for inner ear disease, a review of the literature. Eur Arch Otorhinolaryngol 2006; 263: 791-797.
9. Phillips B, Ball C, Sackett D, et al: Oxford Centre for Evidence-based Medicine levels of evidence (last updated March 2009). www. cebm.net/index.aspx? o = 1025 (accessed July 1, 2009).
10. Garduno-Anaya MA, De Toledo HC, Hinojosa-Gonzalez R, Pane-Pianese C, Rios-Castaneda LC: Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere's disease: A two-year prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 2005: 133; 285-294.
11. Silverstein H, Isaacson JE, Olds MJ, Rowan PT, Rosenberg S: Dexamethasone inner ear perfusion for the treatment of Meniere's disease: A prospective, randomized, doubleblind, crossover trial. Am J Otol 1998; 19: 196-201.
12. Sennaroǧlu L, Sennaroǧlu G, Gursel B, Dini FM: Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease. Otolaryngol Head Neck Surg. 2001; 125: 537-543.
13. Itoh A, Sakata E: Treatment of vestibular disorders. Acta Otolaryngol Suppl 1991; 481: 617-623.
14. Boleas-Aguirre MS, Lin FR, Della Santina CC, Minor LB, Carey JP: Longitudinal results with intratympanic dexamethasone in the treatment of Meniere's disease. Otol Neurotol 2008; 29: 33-38.
15. Barrs DM: Intratympanic injections of dexamethasone for long-term control of vertigo. Laryngoscope 2004; 114: 1910-1914.
16. Hillman TM, Arriaga MA, Chen DA: Intratympanic steroids: Do they acutely improve hearing in cases of cochlear hydrops? Laryngoscope 2003; 113: 1903-1907.
17. Barrs DM, Keyser JS, Stallworth C, McElveen JT Jr: Intratympanic steroid injections for intractable Meniere's disease. Laryngoscope 2001; 111: 2100-2104.
18. Sennaroǧlu L, Dini FM, Sennaroǧlu G, Gursel B, Ozkan S: Transtympanic dexamethasone application in Meniere's disease: An alternative treatment for intractable vertigo. J Laryngol Otol 1999; 113: 217-221.
19. Arriaga MA, Goldman S: Hearing results of intratympanic steroid treatment of endolymphatic hydrops. Laryngoscope 1998; 108: 1682-1685.
20. Shea JJ Jr: The role of dexamethasone or streptomycin perfusion in the treatment of Meniere's disease. Otolaryngol Clin North Am 1997; 30: 1051-1059.
21. Shea JJ Jr, Ge X: Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere's disease. Otolaryngol Clin North Am 1996; 29: 353-358.
22. Silverstein H, Choo D, Rosenberg SI, Kuhn J, Seidman M, Stein I: Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 1996; 75: 468-471.
23. Battaglia A, Burchette R, Cueva R: Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008; 29: 453-460.
24. Ahn JH, Yoo MH, Yoon TH, Chung JW: Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness? Laryngoscope 2008; 118: 279-282.
25. Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, Ferekidis E: Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: A control study. Otolaryngol Head Neck Surg 2006; 134: 940-945.
26. Ho HG, Lin HC, Shu MT, Yang CC, Tsai HT: Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope 2004; 114: 1184-1189.
27. Kilic R, Safak MA, Oquz H, Kargin S, Demirci M, Samim E, Ozluoglu LN: Intratympanic methylprednisolone for sudden sensorineural hearing loss. Otol Neurtol 2007; 28: 312-316.
28. Plaza G, Herraiz C: Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg 2007; 137: 74-78.
29. Van Wijck F, Staecker H, Lefebvre PP: Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol 2007; 127: 1012-1017.
30. Kakehata S, Saski A, Oji K, Futai K, Ota S, Makinae K, Shinkawa H: Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otol Neurotol 2006; 27: 604-608.
31. Lautermann J, Sudhoff H, Junker R: Transtympanic corticoid therapy for acute profound loss. Eur Arch Otorhinolaryngol 2005: 262: 587-591.
32. Roebuck J, Chang CYJ: Efficacy of steroid injection on idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2006; 135: 276-279.
33. Choung YH, Park K, Shin YR, Cho MJ: Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Laryngoscope 2006; 116: 747-752.
34. Plontke S, Lowenheim H, Preyer S, Leins P, Dietz K, Koitschev A, Zimmermann R, Zenner HP: Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: Basis for planning randomized controlled trials. Acta Otolaryngol 2005; 125: 830-839.
35. Dallan I, Bruschini P, Nacci A, et al: Transtympanic steroids as a salvage therapy in sudden hearing loss: Preliminary results. ORL J Otorhinolaryngol Relat Spec 2006; 68: 247-252.
36. Banerjee A, Parnes LS: Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol 2005; 26: 878-881.
37. Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu N: Intratympanic steroid for the treatment of sudden hearing loss. Otolaryngol Head Neck Surg 2005; 133: 251-259.
38. Herr BD, Marzo SJ: Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005; 132: 527-531.
39. Battista RA: Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2005; 132: 902-905.
40. Gouveris H, Selivanova O, Mann W: Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol 2005; 262: 131-134.
41. Lefebvre PP, Staecker H: Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: A pilot study. Acta Otolaryngol 2002; 122: 698-702.
42. Chandrasekhar SS: Intratympanic dexamethasone for sudden sensorineural hearing loss: Clinical and laboratory evaluation. Otol Neurotol 2001; 22: 18-23.
43. Gianoli GJ, Li JC: Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 2001; 125: 142-146.
44. Kopke RD, Hoffer ME, Wester D, O'Leary MJ, Jackson RL: Targeted topical steroids therapy in sudden sensorineural hearing loss. Otol Neurotol 2001; 22: 475-479.
45. Green JD Jr, Blum DJ, Harner SG: Longitudinal followup of patients with Meniere's disease. Otolaryngol Head Neck Surg 1991; 104: 783-788.
46. Silverstein H, Smouha E, Jones R: Natural history vs surgery for Meniere's disease. Otolaryngol Head Neck Surg 1989; 10: 6-16.
47. Chandrasekhar SS: Updates on methods to treat sudden hearing loss. Oper Tech Otolaryngol Head Neck Surg 2003; 14: 288-292.
48. Wilson WR, Byl FM, Laird N: The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol 1980; 106: 772-776.
49. Mattox DE, Simmons FB: Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977; 86: 463-480.
50. Jones N, Ludman H: Acquired sensorineural hearing loss; in Ludman H, Wright T (eds): Diseases of the Ear, ed 6. London, Arnold, 1998, pp 495-497.
51. Rauch SD, Reda DJ: Combined therapy (intratympanic dexamethasone + high-dose prednisone taper) for idiopathic sudden sensorineural hearing loss (comment on Otol Neurotol 2008; 29: 453-460). Otol Neurotol 2009; 30: 254-255, author reply 255-256.
52. Committee on Hearing and Equilibrium AAO-HNS. Committee on Hearing and Equilibrium guidelines for the diagnosis and the evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995; 113: 181-185.
53. National Institutes of Health: Sudden Deafness (publication 00-4757). Bethesda, NIH, 2000.
54. Conlin AE, Parnes LS: Treatment of sudden sensorineural hearing loss. I. A systemic review. Arch Otolaryngol 2007; 133: 573-581.
55. Conlin AE, Parnes LS: Treatment of sudden sensorineural hearing loss. II. A meta-analysis. Arch Otolaryngol 2007; 133: 582-586.